Nocturnal TLA for Severe Allergic Asthma After Withdrawal of Omalizumab Therapy
NCT03480815
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Severe Allergic Asthma
Interventions
DEVICE:
Nocturnal Temperature Controlled Laminar Flow Device
OTHER:
None Device
Sponsor
Chang Gung Memorial Hospital